Nachrichten zur Moderna Inc. Aktie

Moderna chief: Company won’t invest in new late-stage vaccine trials

Moderna has already been facing declines in sales after a boom during the COVID-19 pandemic.…

Stocks making the biggest moves midday: Fortinet, Moderna, Intel, Bausch Health & more

These are the stocks posting the largest moves in midday trading.…

Moderna stock surges for fourth consecutive day, hitting 2024 high By Investing.com

Moderna stock surges for fourth consecutive day, hitting 2024 high…

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV By Reuters

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV…

Moderna curbing investments in vaccine trials due to US backlash, CEO tells Bloomberg TV

Moderna does not plan to invest in new late-stage vaccine trials because of growing opposition to immunizations from U.S. officials,…

Mehr als nur Covid: Wie Moderna mit KI und mRNA den Krebs besiegen will

Trotz aktueller operativer Verluste sichert das Unternehmen seine Zukunft durch ein massives Cash-Polster von über 8 Mrd. USD ab…

Moderna: Das lange Warten auf den Krebs-Durchbruch könnte bald ein Ende haben

Wir schreiben Januar 2026, und ein Blick auf den Aktienkurs von Moderna zeigt, dass der "Long Covid"-Effekt an der Börse…

Why Moderna Stock Surged Today

The vaccine maker is expanding beyond its COVID-focused offerings.…

Moderna (MRNA) Increases Despite Market Slip: Heres What You Need to Know

Moderna (MRNA) closed at $43 in the latest trading session, marking a +2.8% move from the prior day.…

Moderna (MRNA) Increases Despite Market Slip: Heres What You Need to Know

Moderna (MRNA) closed the most recent trading day at $40.6, moving +2.52% from the previous trading session.…

Warum der Einstieg bei Moderna meines Erachtens zum jetzigen Zeitpunkt eine vielversprechende Chance darstellt!

Die Aktie von Moderna befindet sich in einem mehrjährigen Abwärtstrend und könnte nun eine Bodenbildung vollziehen, nachdem das Unternehmen am…

Health Care Roundup: Market Talk

Find insight on Merck & Co., Moderna and more in the latest Market Talks covering Health Care.…

Stocks making the biggest moves midday: JPMorgan, Moderna, Boeing, Cardinal Health, Chipotle & more

These are some of the stocks posting the largest midday moves.…

Moderna: V940/Keytruda Data And Vaccine Revenues Drive A High-Risk Recovery Story

…

Market movers: Synchrony Financial, Capital One, NextSource Materials, Moderna...

…

Moderna expects 2025 revenue of $1.9B, above guidance

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) said it expects 2025 revenue of approximately $1.9 billion, about $100 million above the midpoint of…

Moderna stock rises as revenue outlook exceeds estimates By Investing.com

Moderna stock rises as revenue outlook exceeds estimates…

Moderna expects $1.9 billion in sales, trims costs forecast for 2025

Moderna said on Monday it expects to report around $1.9 ?billion in sales for 2025, putting it near the upper…

Moderna (MRNA) Stock Sinks As Market Gains: Heres Why

In the latest trading session, Moderna (MRNA) closed at $33.86, marking a -5.66% move from the previous day.…

Moderna Aktie: Kursziel rauf - doch BofA sieht weiter Abwärtsrisiken

Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse von BofA Securities:Tim Anderson, Analyst von BofA Securities, stuft die Aktie von Moderna Inc. (ISIN: US60770K1079,…

Moderna just had its best day since October. Heres whats going on, and what analysts expect

Analysts pointed to an upcoming health care conference and cancer data study release as potential catalysts for Modernas ongoing rally.…

Moderna Aktie: Warum die Umsatzhoffnung jetzt wackelt

Zürich (www.aktiencheck.de) - Moderna-Aktienanalyse der UBS:UBS habe die Aktie von Moderna Inc. (ISIN: US60770K1079, WKN: A2N9D9, Ticker-Symbol: 0QF, NASDAQ-Symbol: MRNA)…

Bayer verklagt Corona-Impfstoffhersteller

Der Pharmakonzern Bayer hat die Corona-Impfstoffhersteller Pfizer, BioNTech und Moderna verklagt. Der Vorwurf: Sie hätten mit ihren mRNA-Vakzinen Patente verletzt.…

Pharma: Bayer verklagt Biontech, Pfizer und Moderna wegen Patenten von Corona-Impfstoffen

Bayer wirft mehreren Herstellern vor, eine alte Technologie kopiert zu haben, um mRNA-Impfstoffe herzustellen. Ziel sei Schadenersatz, aber kein Verkaufsverbot.…

MRNA Stock Jumps on Global Submissions Seeking Nod for Flu Vaccine

Moderna jumps after filings seeking approval for its mRNA-1010 flu vaccine across major markets, with plans to launch the shot…

Moderna reaffirms 2025-26 guidance, eyes multiple vaccine, oncology, and rare disease launches

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) on Monday reiterated its 2025 revenue guidance of $1.6 billion to $2 billion and outlined its pipeline…

Moderna (MRNA) Falls More Steeply Than Broader Market: What Investors Need to Know

In the closing of the recent trading day, Moderna (MRNA) stood at $30.41, denoting a -2.38% move from the preceding…

Moderna (MRNA) Stock Dips While Market Gains: Key Facts

The latest trading day saw Moderna (MRNA) settling at $32.29, representing a -7.48% change from its previous close.…

Down 80%, Should You Buy the Dip on Moderna?

Your decision on whether to invest now depends to some extent on your investment strategy.…

CHMP Backs EU Approval of MRNAs New COVID-19 Vaccine mNexspike

CHMP backs EU approval of Modernas next-generation mNexspike COVID-19 vaccine, with a final European Commission decision expected shortly.…

XOMA Royalty Enters into Agreement to Acquire Generation Bio

- Acquisition provides XOMA Royalty with potential milestone and royalty payments under Generation Bio’s collaboration with Moderna -…

Moderna Aktie: Analyst senkt Kursziel auf 28 USD - Fundamentaldaten rücken in den Fokus

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Morgan Stanley:Der Analyst Terence Flynn von Morgan Stanley hat das Kursziel für die Aktie…

Moderna 2026 Covid and RSV growth not enough to boost stock, Jefferies says

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) has been awarded a ‘Hold’ rating and $30 price target, implying limited upside, from Jefferies analysts…

Moderna Aktie: Jefferies sieht Licht, aber langfristige Risiken bleiben - Mehr als Kostensenkungen nötig

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Jefferies & Co:Die Analysten von Jefferies & Co stufen die Aktie von Moderna Inc.…

Nanexa and Moderna enter into license and option agreement for the development of PharmaShell®-based products

Uppsala Sweden, December 10, 2025. The agreement covers the development of up to five undisclosed compounds. Nanexa will receive an…

Market movers: Charbone Hydrogen, Moderna, Synopsys...

…

Stocks making the biggest moves premarket: Synopsys, Moderna, Micron Technology, Wynn Resorts, Coinbase and more

These are some of the stocks posting the largest moves in premarket trading.…

Moderna stock slides as FDA moves to tighten vaccine guidelines

Moderna Inc (NASDAQ:MRNA, XETRA:0QF) stock fell sharply on the news that the Food and Drug Administration (FDA) plans to implement…

Moderna Aktienanalyse: Wachstumsschub ab 2026 erwartet - trotz kurzfristiger Kurszielanpassung

Bad Marienberg (www.aktiencheck.de)???? Moderna im Fokus: Piper Sandler senkt Kursziel auf 63 USD - Rating "overweight" bleibt klar bestehenDie US-Investmentbank…

Moderna Aktie: Positive Überraschung - doch Risiken bleiben brandgefährlich!

Boston, MA (www.aktiencheck.de) - Moderna-Aktienanalyse der Leerink Partners:Leerink habe nach dem jährlichen Investorentag des Biotech-Unternehmens, bei dem Moderna ein Update…

Moderna Aktie: Kursziel erhöht, doch die Warnung bleibt deutlich!

New York (www.aktiencheck.de) - Moderna-Aktienanalyse von Wolfe Research:Wolfe Research habe das Kursziel für die Aktie von Moderna (ISIN: US60770K1079, WKN:…

Moderna takes $1.5 billion loan, expects 10% revenue growth next year

Moderna said on Thursday it secured a five-year loan of $1.5 billion from Ares Management , as it targets up…

Berenberg belässt Biontech auf Buy - Ziel 150 Dollar

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Biontech mit einem Kursziel von 150 US-Dollar auf "Buy"…

Moderna Aktie: Zukunftshoffnung wackelt!

Charlotte (www.aktiencheck.de) - Moderna-Aktienanalyse der Bank of America (BofA):BofA Securities habe das Kursziel für die Aktie von Moderna Inc. (ISIN:…

Telemark Asset Management Builds Position in Beaten-Down Biotech Stock.

Key PointsInitiated stake: 500,000 shares, an estimated $12.91 million increasePost-trade Moderna position: 500,000 shares, valued at $12.91 millionModerna now accounts…

Stock Market Today: Dow, S&P 500, Nasdaq Set to Open Up; Tesla, Nvidia, Datadog, Marvell, Moderna, More Movers

Dow, S&P 500, and Nasdaq futures are rising in premarket trading as the stock market digests the latest labor market…

Earnings live: Moderna stock pops amid cost-cutting efforts, Snap stock soars, Duolingo plunges

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during…

Moderna Q3 Earnings Beat, Stock Up on Revised 25 Spending Plans

MRNA posts narrower-than-expected Q3 loss and lifts liquidity outlook for 2025, as cost cuts and revised spending plans boost investor…

Moderna trims top end of full-year forecast on weak COVID vaccine sales

…

Moderna: Saisonal stark dank Impfstoffnachfrage im November

Moderna ist ein US-Biotechnologieunternehmen mit Sitz in Cambridge, Massachusetts, das auf die Entwicklung von Medikamenten auf Basis der mRNA-Technologie spezialisiert…